More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.96B
EPS
-3.82
P/E ratio
--
Price to sales
--
Dividend yield
8.696%
Beta
1.333045
Previous close
$18.93
Today's open
$18.88
Day's range
$18.50 - $18.95
52 week range
$16.41 - $21.17
CEO
John P. Calamos Sr.
Employees
--
Headquarters
Naperville, IL
Exchange
Nasdaq Global Select
Shares outstanding
158887622
Issue type
Common Stock
Finance
Asset Management Services
CSQ: Discount Remains Appealing With Strong Monthly Distribution
Calamos Strategic Total Return Fund remains attractive for income investors, trading at an attractive discount for entry. CSQ delivered two distribution increases this year, totaling a 32% boost, reflecting strong underlying equity performance in recent years. Combining the discount with the latest tech/AI space, seeing some increased volatility, makes CSQ even more appealing to consider.
Seeking Alpha • Nov 9, 2026

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
METRO CHICAGO, Ill., Nov. 2, 2026 /PRNewswire/ -- Calamos Investments®* has announced monthly distributions and sources of distributions paid in November 2026 to shareholders of its seven closed-end funds (the Funds) pursuant to the Funds' respective distribution plans.
PRNewsWire • Nov 2, 2026

10 Best CEFs This Month: Average Yield Of 11% (October 2026)
The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 10.9% yield and a 7.5% discount to NAV. Selections emphasize sector diversification, long-term outperformance, sustainable distributions, and attractive valuations, with a focus on both equity and credit-oriented CEFs. CEFs are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone.
Seeking Alpha • Oct 31, 2026

CSQ Bio® Announces CSQ Bio® – Surgical and Introduces INNESTO Rx™ Surgical Collagen Powder
SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- #biologics--CSQ Bio® today announced the introduction of CSQ Bio® – Surgical, its surgical-focused business, and unveiled INNESTO Rx™, a CSQ Bio®-branded surgical collagen powder. National commercial sales of INNESTO Rx™ are scheduled to begin January 4, 2027. The underlying collagen product is FDA 510(k)-cleared. CSQ Bio® – Surgical will focus on national commercialization of surgical products, working with manufacturers and healthcare organizations on product introduct.
Business Wire • Oct 13, 2026

CSQ: Strong Performance, But Leverage And Fees Limit Upside
Calamos Strategic Total Return Fund is a $5.2B CEF focused on equities, convertibles, and high-yield credit, employing significant leverage. CSQ has delivered strong historical NAV returns and supports its sizable 7.8% dividend primarily through capital appreciation rather than income. Despite robust performance, I rate CSQ a Hold due to its current 7.8% discount not offering a sufficient margin of safety given 30% leverage and high fees.
Seeking Alpha • Sep 28, 2026

CSQ: Positioned For Growth In A Higher-Rate Market
Calamos Strategic Total Return Fund is rated Buy, leveraging diversified equities and fixed income with a strong tilt toward information technology and financials. CSQ's overweight in AI-driven mega-cap tech and financials positions the fund for outperformance amid a risk-on market and ongoing AI capital investment cycles. Convertible bonds and preferred stock holdings add income durability, while 30% leverage aims to amplify returns despite macroeconomic volatility.
Seeking Alpha • Sep 28, 2026

Calamos Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CHW, CGO and CCD) Announce Private Placements Totaling $248.25 Million of Mandatory Redeemable Preferred Shares
METRO CHICAGO, Ill., Aug. 26, 2026 /PRNewswire/ -- The Boards of Trustees of six of Calamos Investments' closed-end funds (the Funds) today announced the issuance of additional series of mandatory redeemable preferred (MRP) shares totaling $248.25 million.
PRNewsWire • Aug 26, 2026

CSQ: Trading Below Its Historical Discount
Calamos Strategic Total Return Fund remains a buy, trading at a 9.13% discount to NAV and offering a 7.8% dividend yield. CSQ's portfolio blends large-cap tech equities and income securities, but relies heavily on net realized gains to support distributions. Leverage at 27.78% and interest rate sensitivity present risks, especially if rates rise or tech sentiment shifts negatively.
Seeking Alpha • Jul 13, 2026

CSQ: Monthly Distribution Delivering Strong Returns And At A Deep Discount
Calamos Strategic Total Return Fund offers a compelling entry point with a -9.79% discount, well below its last decade historical average. CSQ has outperformed SPY over the last 10 years, driven by leverage on significant exposure to mega-cap tech and convertible securities. The fund raised its monthly distribution at the start of this year to its highest level since inception, yielding 7.18% and maintaining a tax-friendly profile.
Seeking Alpha • Jun 1, 2026

10 Best CEFs This Month: Average Yield Of 9% Plus (May 2026)
The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 9% plus yield and nearly 7.5% NAV discount. Selections emphasize sector diversification, long-term outperformance, sustainable distributions, and attractive valuations, with a focus on both equity and credit-oriented CEFs. CEFs are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone.
Seeking Alpha • May 23, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Calamos Strategic Total Return Fund commission-free¹. Build wealth for the long term using automated trading and transfers.